To our knowledge, the targeted differentiation of cancer cells was only achieved in neuroblastoma cells upon retinoid-induced ablation of their main oncogenic driver MYCN [40] but previously not in any type of carcinoma. This evidence concerns the gene MYCN and neuroblastoma.